These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4000334)

  • 1. Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets.
    Woo KT; Wei SS; Lee EJ; Lau YK; Lim CH
    Nephron; 1985; 40(1):25-8. PubMed ID: 4000334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galloway memorial lecture. Platelet injury and antithrombin III in clinical nephrology.
    Woo KT
    Ann Acad Med Singap; 1985 Apr; 14(2):394-403. PubMed ID: 3898986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Lai KN; Yin JA; Yuen PM; Li PK
    Nephron; 1990; 56(3):271-6. PubMed ID: 2150218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin-III and platelets in haemodialysis patients.
    Brandt P; Jespersen J; Sørensen LH
    Nephron; 1981; 28(1):1-3. PubMed ID: 7266723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombin III in chronic renal insufficiency].
    Bekić-Kaluza S; Macanović M
    Med Arh; 1991; 45(1-2):3-8. PubMed ID: 1366314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased reticulated platelets in dialysis patients.
    Himmelfarb J; Holbrook D; McMonagle E; Ault K
    Kidney Int; 1997 Mar; 51(3):834-9. PubMed ID: 9067918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombin III activity during hemodialysis].
    Rydzewski A; Soszka J; Myśliwiec M
    Pol Arch Med Wewn; 1983 Feb; 69(2):123-8. PubMed ID: 6889150
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelets and antithrombin III in uraemia: the acute effect of haemodialysis.
    Knudsen F; Dyerberg J
    Scand J Clin Lab Invest; 1985 Jun; 45(4):341-7. PubMed ID: 3160101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure.
    Langley PG; Keays R; Hughes RD; Forbes A; Delvos U; Williams R
    Hepatology; 1991 Aug; 14(2):251-6. PubMed ID: 1860682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis membranes and coagulation system.
    Notohamiprodjo M; Andrassy K; Bommer J; Ritz E
    Blood Purif; 1986; 4(1-3):130-41. PubMed ID: 2942155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma antithrombin III concentration in patients on regular haemodialysis treatment.
    Jørgensen M; Eriksen HO; Tranebjaerg L
    Nephron; 1985; 40(1):22-4. PubMed ID: 4000333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function in patients on long term peritoneal dialysis.
    Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G
    Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
    Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis.
    Sokunbi D; Wadhwa NK; Solomon M; Suh H
    Adv Perit Dial; 1993; 9():156-60. PubMed ID: 8105912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin III and heparinemia in patients on hemodialysis].
    Nagami AE; Sesin AM; Nattero GN
    Rev Fac Cien Med Univ Nac Cordoba; 1988; 46(1):23-6. PubMed ID: 3273332
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating aggregated platelets, number of platelets per aggregate and platelet size in chronic dialysis patients.
    Winkler J; Fuchs J; Morduchowicz G; Boner G; Sulkiss J; Weinberger I
    Nephron; 1997; 77(1):44-7. PubMed ID: 9380237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure.
    Moorthy AV; Rosenblum M; Rajaram R; Shug AL
    Am J Nephrol; 1983; 3(4):205-8. PubMed ID: 6614070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.